Bayer to buy biotech firm AskBio for up to US$4bn
Bayer AG agreed to acquire US biotech company Asklepios BioPharmaceutical Inc (AskBio) for as much as US$4 billion, bolstering its pharma division with experimental gene therapies before patents expir